Statistics
Publications
170
Citations
35.7K
H-Index
73
Active since
2003
Patrick A. Ott is an author at Dana-Farber Cancer Institute specializing in oncology, cancer immunotherapy, and medicine.
Publications per year
2003–2025
170
170
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott, Zhuting Hu, Derin B. Keskin et al. · Nature · 2017 · 2.9K citations
Medicine, Immunology, Oncology +12
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
Michael A. Postow, Jason Chesney, Anna C. Pavlick et al. · New England Journal of Medicine · 2015 · 2.8K citations · Full text
Life Sciences, Immunology, Oncology +17
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
Răzvan Cristescu, Robin Mogg, Mark Ayers et al. · Science · 2018 · 2.3K citations
Medicine, Immunology, Oncology +17
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby‐Arnon, Parin Shah, Michael S. Cuoco et al. · Cell · 2018 · 1.4K citations · Full text
Medicine, Cancer Biology, Oncology +12
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin, Annabelle Anandappa, Jing Sun et al. · Nature · 2018 · 1.4K citations · Full text
Medicine, Immunology, Oncology +16
1–5 of 170